Challenges of phase III trial design for novel treatments in diseases with no standard treatment: The AZA-001 myelodysplasia study model

Pierre Fenaux, John F. Seymour, Valeria Santini, Lew Silverman, Steven Gore, Alan List, Guillermo Sanz, Ghulam J. Mufti, Eli Estey, Arlene S. Swern, C. L. Beach, Eva Hellstrom-Lindberg

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Challenges of phase III trial design for novel treatments in diseases with no standard treatment: The AZA-001 myelodysplasia study model'. Together they form a unique fingerprint.

Medicine & Life Sciences